NOVATO, CA / ACCESSWIRE / November 1, 2021 / Mosaic ImmunoEngineering Inc. ("Mosaic" or the "Company"), (OTCQB:CPMV), a development-stage biotechnology company focused on bridging immunology and ...
- Research grants provided by the National Cancer Institute will support continued development and study of cowpea mosaic virus (CPMV) as an immuno-oncology candidate - - One grant will focus on ...
BOULDER , CO, UNITED STATES, February 24, 2026 /EINPresswire.com/ — Mosaic Biosciences, a protein discovery and engineering company enabling the development of next ...
NOVATO, CA / ACCESSWIRE / November 1, 2021 / Mosaic ImmunoEngineering Inc. ("Mosaic" or the "Company"), (OTCQB:CPMV), a development-stage biotechnology company focused on bridging immunology and ...